신생아 저산소 허혈 뇌증의 약물 치료적 접근 = Pharmacological Approaches in Newborn Infants with Hypoxic Ischemic Encephalopathy

다국어 초록 (Multilingual Abstract)

Despite marked improvements in perinatal practice, neonatal hypoxic-ischemic encephalopathy (HIE) remains one of the major causes of acute mortality and chronic neurologic disability in infants and children. Several new therapeutic approaches aiming at this condition have been used in the last decade, including therapeutic hypothermia and many pharmacological agents. Therapeutic hypothermia remarkably reduces death and neurological impairment, and has therefore rapidly become the standard therapy for full-term newborn infants with moderate-to-severe HIE. However, despite these promising outcomes of therapeutic hypothermia, approximately 50% of the infants treated with hypothermia have an adverse outcome. Therefore, there exists an urgent need for other treatment options. A mechanistically driven approach to HIE has resulted in the development of many drugs that are potent antagonists of specific steps in cascades of molecular reactions in HI injury. This review provides an overview of promising pharmacological approaches of neuroprotection that may be used in clinical practice. Although several drugs have been found to be effective in preclinical evaluations, such antagonists have been ineffective in human trials.
Failure has been attributed to many factors such as the complex pathology of HIE in neonates, the inevitable delays in initiation of therapy in clinical practice, and the side effects of the drugs. Moreover, many of these drugs interfere with only one step of the cascades, while multiple biochemical cascades are put in motion simultaneously. Therefore, neuroprotective strategies such as hypothermia have to deal with multiple cascades. Research is now being focused on drugs that may act synergistically or additively with hypothermia, with the hope that combination therapy might augment neuroprotection.

참고문헌 (Reference)

• 1 김행미, "편마비를 가진 뇌성마비 환아에서 확산 텐서강조영상을 Erythropoietin의 투여가 신생백서 저산소허혈뇌손상에 미치는 영향" 대한소아과학회 52 (52): 105-110, 2009
• 2 곽수희, "열 전처지가 신생쥐의 허혈성 저산소성 뇌손상에 미치는 영향" 대한신생아학회 15 (15): 32-37, 2008
• 3 박창로, "신생쥐의 저산소성 허혈성 뇌손상에서 손상 후 덱사메타손의 투여 효과" 대한소아과학회 46 (46): 989-995, 2003
• 4 장미영, "신생아 저산소성 허혈성 뇌증의 저체온 치료" 대한신생아학회 20 (20): 2-11, 2013
• 5 Preckel B, "Xenon produces minimal haemodynamic effects in rabbits with chronically compromised left ventricular function" 88 : 264-269, 2002
• 6 Chakkarapani E, "Xenon enhances hypothermic neuroprotection in asphyxiated newborn pigs" 68 : 330-341, 2010
• 7 Faulkner S, "Xenon augmented hypothermia reduces early lactate/N-acetylaspartate and cell death in perinatal asphyxia" 70 : 133-150, 2011
• 8 Ma D, "Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia" 58 : 182-193, 2005
• 9 Robertson NJ, "Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?" 160 : 544-552, 2012
• 10 Liu Y, "Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats" 35 : 1460-1465, 2004
• 11 Filippi L, "Topiramate concentrations in neonates treated with prolonged whole body hypothermia for hypoxic ischemic encephalopathy" 50 : 2355-2361, 2009
• 12 Kwan SL, "Therapeutic effect of transforming growth factor (TGF)-β1 in neonatal rat model of hypoxic-ischemic brain damage" 7 : 154-160, 2000
• 13 Hong IH, "Therapeutic effect of nimodipine in neonatal rat model of cerebral hypoxia-ischemia" 42 : 1552-1558, 1999
• 14 Glier C, "Therapeutic doses of topiramate are not toxic to the developing rat brain" 187 : 403-409, 2004
• 15 Levene MI, "The use of a calcium-channel blocker, nicardipine, for severely asphyxiated newborn infants" 32 : 567-574, 1990
• 16 Paris A, "The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the alpha2A-adrenoceptor subtype" 102 : 456-461, 2006
• 17 Shah N, "The effect of recombinant human erythropoietin on the development of retinopathy of prematurity" 27 : 67-71, 2010
• 18 Probyn ME, "The anti-inflammatory agent N-acetyl cysteine exacerbates endotoxin-induced hypoxemia and hypotension and induces polycythemia in the ovine fetus" 98 : 118-127, 2010
• 19 Vásquez -Vivar J, "Tetrahydrobiopterin in the prevention of hypertonia in hypoxic fetal brain" 66 : 323-331, 2009
• 20 Cilio MR, "Synergistic neuroprotective therapies with hypothermia" 15 : 293-298, 2010
• 21 Patti G, "Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting. Results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting) study" 61 : 1379-1387, 2013
• 22 Sierra S, "Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood-brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death" 23 : 307-318, 2011
• 23 Li A, "Simvastatin attenuates hypomyelination induced by hypoxia-ischemia in neonatal rats" 32 : 945-952, 2010
• 24 Vohr BR, "School-age outcomes of very low birth weight infants in the indomethacin intraventricular hemorrhage prevention trial" 111 : e340-e346, 2003
• 25 Filippi L, "Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI)" 12 : 144-, 2012
• 26 Gupta P, "Safety and efficacy of prolonged dexmedetomidine use in critically ill children with heart disease*" 13 : 660-666, 2012
• 27 Whyte IM, "Safety and efficacy of intravenous N-acetylcysteine for acetaminophen overdose: analysis of the Hunter Area Toxicology Service (HATS) database" 23 : 2359-2368, 2007
• 28 Kortsalioudaki C, "Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure" 14 : 25-30, 2008
• 29 Peng B, "Remote ischemic postconditioning protects the brain from global cerebral ischemia/reperfusion injury by up-regulating endothelial nitric oxide synthase through the PI3K/Akt pathway" 1445 : 92-102, 2012
• 30 Ehrenreich H, "Recombinant human erythropoietin in the treatment of acute ischemic stroke" 40 : e647-e656, 2009
• 31 Coburn M, "Randomized controlled trial of the haemodynamic and recovery effects of xenon or propofol anaesthesia" 94 : 198-202, 2005
• 32 Tsuji M, "Protective effect of aminoguanidine on hypoxic-ischemic brain damage and temporal profile of brain nitric oxide in neonatal rat" 47 : 79-83, 2000
• 33 Dworschak M, "Pharmacologic neuroprotection--is xenon the light at the end of the tunnel?" 36 : 2477-2479, 2008
• 34 van den Broek MP, "Pharmacokinetics and clinical efficacy of phenobarbital in asphyxiated newborns treated with hypothermia: a thermopharmacological approach" 51 : 671-679, 2012
• 35 McAdams RM, "Outcomes of extremely low birth weight infants given early high-dose erythropoietin" 33 : 226-230, 2013
• 36 Mehmet S, "One-year experience in the retinopathy of prematurity: frequency and risk factors, short-term results and follow-up" 4 : 634-640, 2011
• 37 Gidday JM, "Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning" 19 : 331-340, 1999
• 38 Kim HM, "Neuroprotective strategies in neonatal hypoxic ischemic brain injury" 16 : 123-133, 2004
• 39 Rajakumaraswamy N, "Neuroprotective interaction produced by xenon and dexmedetomidine on in vitro and in vivo neuronal injury models" 409 : 128-133, 2006
• 40 Schubert S, "Neuroprotective effects of topiramate after hypoxia-ischemia in newborn piglets" 1058 : 129-136, 2005
• 41 Yu Jin Kim, "Neuroprotective effects of L-carnitine against oxygenglucose deprivation in rat primary cortical neurons" 대한소아과학회 55 (55): 238-248, 2012
• 42 Zheng XR, "Neuroprotection of VEGF-expression neural stem cells in neonatal cerebral palsy rats" 230 : 108-115, 2012
• 43 장윤정, "Neuroprotection of Recombinant Human Erythropoietin Via Modulation of N-methyl-D-aspartate Receptors in Neonatal Rats with Hypoxic-ischemic Brain Injury" 대한신생아학회 16 (16): 221-233, 2009
• 44 Scafidi S, "Neuroprotection by acetyl-L-carnitine after traumatic injury to the immature rat brain" 32 : 480-487, 2010
• 45 Perlman JM, "Neonatal resuscitation: 2010 International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations" 126 : e1319-e1344, 2010
• 46 Thomson Reuters Clinical Editorial Staff, "Neofax 2011" Thomson Reuters 2011
• 47 Paintlia MK, "Nacetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain" 78 : 347-361, 2004
• 48 Ahola T, "N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: a randomized controlled trial" 143 : 713-719, 2003
• 49 Chen YC, "Melatonin utility in neonates and children" 111 : 57-66, 2012
• 50 Gitto E, "Melatonin reduces oxidative stress in surgical neonates" 39 : 184-189, 2004
• 51 Bouslama M, "Melatonin prevents learning disorders in brain-lesioned newborn mice" 150 : 712-719, 2007
• 52 Robertson NJ, "Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model" 136 : 90-105, 2013
• 53 Torrance HL, "Maternal allopurinol during fetal hypoxia lowers cord blood levels of the brain injury marker S-100B" 124 : 350-357, 2009
• 54 Zhou Y, "Isoflurane posttreatment reduces neonatal hypoxic-ischemic brain injury in rats by the sphingosine-1-phosphate/ phosphatidylinositol-3-kinase/Akt pathway" 41 : 1521-1527, 2010
• 55 Ballard RA, "Inhaled nitric oxide in preterm infants undergoing mechanical ventilation" 355 : 343-353, 2006
• 56 Schreiber MD, "Inhaled nitric oxide in premature infants with the respiratory distress syndrome" 349 : 2099-2107, 2003
• 57 Minamishima S, "Inhaled nitric oxide improves outcomes after successful cardiopulmonary resuscitation in mice" 124 : 1645-1653, 2011
• 58 Lin S, "IGF-1 protects oligodendrocyte progenitor cells and improves neurological functions following cerebral hypoxia-ischemia in the neonatal rat" 1063 : 15-26, 2005
• 59 Elmahdy H, "Human recombinant erythropoietin in asphyxia neonatorum: pilot trial" 125 : e1135-e1142, 2010
• 60 Ben Abdennebi H, "How to protect liver graft with nitric oxide" 17 : 2879-2889, 2011
• 61 Alonso-Alconada D, "Histological study of the protective effect of melatonin on neural cells after neonatal hypoxia-ischemia" 27 : 771-783, 2012
• 62 Nijboer CH, "Gender-specific neuroprotection by 2-iminobiotin after hypoxia-ischemia in the neonatal rat via a nitric oxide independent pathway" 27 : 282-292, 2007
• 63 Signorini C, "Free iron, total F-isoprostanes and total Fneuroprostanes in a model of neonatal hypoxic-ischemic encephalopathy: neuroprotective effect of melatonin" 46 : 148-154, 2009
• 64 Kelen D, "Experimental treatments for hypoxic ischaemic encephalopathy" 86 : 369-377, 2010
• 65 Bonfils PK, "Estimation of the hypothermic component in neuroprotection provided by cannabinoids following cerebral ischemia" 49 : 508-518, 2006
• 66 Andropoulos DB, "Erythropoietin neuroprotection in neonatal cardiac surgery: a phase I/II safety and efficacy trial" 146 : 124-131, 2013
• 67 Zhu C, "Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy" 124 : e218-e226, 2009
• 68 Wu YW, "Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics" 130 : 683-691, 2012
• 69 Gitto E, "Effects of melatonin treatment in septic newborns" 50 : 756-760, 2001
• 70 Perrone S, "Effects of lutein on oxidative stress in the term newborn: a pilot study" 97 : 36-40, 2010
• 71 Sato H, "Early replacement therapy in a first Japanese case with autosomal recessive guanosine triphosphate cyclohydrolase I deficiency with a novel point mutation" 2013
• 72 Lampl Y, "Early outcome of acute ischemic stroke in hyperlipidemic patients under atorvastatin versus simvastatin" 33 : 129-134, 2010
• 73 Cariou A, "Early high-dose erythropoietin therapy and hypothermia after out-of-hospital cardiac arrest: a matched control study" 76 : 397-404, 2008
• 74 Sarkar S, "Does phenobarbital improve the effectiveness of therapeutic hypothermia in infants with hypoxicischemic encephalopathy?" 32 : 15-20, 2012
• 75 Afonso J, "Dexmedetomidine: current role in anesthesia and intensive care" 62 : 118-133, 2012
• 76 Liachenko S, "Deferoxamine improves early postresuscitation reperfusion after prolonged cardiac arrest in rats" 23 : 574-581, 2003
• 77 Papazisis G, "Deferoxamine decreases the excitatory amino acid levels and improves the histological outcome in the hippocampus of neonatal rats after hypoxia-ischemia" 57 : 73-78, 2008
• 78 Jacobs SE, "Cooling for newborns with hypoxic ischaemic encephalopathy" 1 : CD003311-, 2013
• 79 Chen CM, "Conditions associated with hypertension in a high-risk premature infant" 71 : 485-490, 2008
• 80 Jatana M, "Combination of systemic hypothermia and N-acetylcysteine attenuates hypoxic-ischemic brain injury in neonatal rats" 59 : 684-689, 2006
• 81 Haiden N, "Changes in thrombopoiesis and platelet reactivity in extremely low birth weight infants undergoing erythropoietin therapy for treatment of anaemia of prematurity" 93 : 118-123, 2005
• 82 Nelson KB, "Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?" 95 : 263-269, 1995
• 83 Martin JL, "Asynchronous administration of xenon and hypothermia significantly reduces brain infarction in the neonatal rat" 98 : 236-240, 2007
• 84 Aly H, "Ascorbic acid combined with ibuprofen in hypoxic ischemic encephalopathy: a randomized controlled trial" 29 : 438-443, 2009
• 85 Johannessen Landmark C, "Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy" 22 : 27-47, 2008
• 86 Kaandorp JJ, "Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-Trial); a randomized double blind placebo controlled multicenter study" 10 : 8-, 2010
• 87 Clancy RR, "Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest" 108 : 61-70, 2001
• 88 Chaudhari T, "Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathy" 7 : CD006817-, 2012
• 89 Levene M, "Acute effects of two different doses of magnesium sulphate in infants with birth asphyxia" 73 : F174-F177, 1995
• 90 Rouse DJ, "A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy" 359 : 895-905, 2008
• 91 Juul SE, "A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety" 122 : 383-391, 2008